| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1261606B1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 02/23/2005 | EP1140125B1 Extracts of celery seed for the prevention and treatment of inflammation and gastrointestinal irritation |
| 02/23/2005 | EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents |
| 02/23/2005 | EP1058544B1 Inhibition of tnf activity with compositions comprising heparin and soluble tnf recpetors |
| 02/23/2005 | CN1585778A Modified anti-TNF alpha antibody |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585757A Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585750A Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/23/2005 | CN1585645A Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 02/23/2005 | CN1585641A Hydrazono-malonitriles |
| 02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1584020A Differentiation of adipose stromal cells into osteobalsts and uses thereof |
| 02/23/2005 | CN1583745A Amino biological pterin derivative and pharmaceutical use thereof |
| 02/23/2005 | CN1583142A Pills for promoting blood circulation and removing obstruction in channels |
| 02/23/2005 | CN1583133A Effervescent tablets for bone diseases and their preparation |
| 02/23/2005 | CN1583089A Chinese herbal medicinal composition for hyperosteogeny |
| 02/23/2005 | CN1583085A Chinese patent medicine for injury of muscle and joint and its preparation |
| 02/23/2005 | CN1583069A Medicine for osteoporosis |
| 02/23/2005 | CN1583065A External used paste for intervertebral disc protrusion and its preparation |
| 02/23/2005 | CN1583063A Extraction of effective components from frankinscene and its preparation and use |
| 02/23/2005 | CN1583062A Medicinal ointment for bone injury |
| 02/23/2005 | CN1583061A Medicinal ointment for intervertebral disc protrusion |
| 02/23/2005 | CN1583060A Chinese patent medicine for enterogastric heat retention waist and knee aching pain and joint tingling and its preparation |
| 02/23/2005 | CN1583058A Medicinal spirit for rheumatic arthritis |
| 02/23/2005 | CN1583035A Quick bone fracture ointment |
| 02/23/2005 | CN1583026A Paste for pain caused by shoulder periarthritis |
| 02/23/2005 | CN1583022A External used Chinese medicinal preparation for bone fracture and its preparing method |
| 02/23/2005 | CN1583010A Extracts of Chinese medicines for rheumatism and its preparation and preparing method |
| 02/23/2005 | CN1582998A Medicine for hyperosteogeny and its preparation |
| 02/23/2005 | CN1582991A Medicine for bone fracture |
| 02/23/2005 | CN1582961A Improved Chinese medicinal paste for arthralgia and its preparation |
| 02/23/2005 | CN1582949A Enteric soluble preparation of Alun phosphorate and its preparing method |
| 02/23/2005 | CN1582931A Oral sustained releasing micro-tablets of tuduranine and their preparation |
| 02/23/2005 | CN1582918A Prescription of soybean isoflavone tablets |
| 02/23/2005 | CN1190491C PRV-gene and use thereof |
| 02/23/2005 | CN1190437C Pteridine compounds for treatment of psoriasis |
| 02/23/2005 | CN1190424C Quinoline-containing Alpha-ketoamide cysteine and serine protease inhibitors |
| 02/23/2005 | CN1190420C Non-peptide neomatal vascularization inhibitor |
| 02/23/2005 | CN1190416C Substituted phenyl alkyl nitrogen monoxide synthase inhibitor and its prepn. and use |
| 02/23/2005 | CN1190240C Composite transplant containing concanavalin A and its preparation and application |
| 02/23/2005 | CN1190227C External-use Chinese medicine preparation for wind-dispelling and dampness-removing and preparing method thereof |
| 02/23/2005 | CN1190218C Chinese medicine for treating hyperosteogeny |
| 02/23/2005 | CN1190216C Medicine for treating lumber intervertebral disk protrusion and its preparing process |
| 02/23/2005 | CN1190210C Medical wine for treating hyperosteogeny and its preparing method |
| 02/23/2005 | CN1190204C Medicine for treating hyperosteogeny in cervical vertebra and lumbar vertebra |
| 02/23/2005 | CN1190199C Medicinal use and prepn. process of general ketosteroid of Tinospora Hainanesis |
| 02/22/2005 | US6858739 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/22/2005 | US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/22/2005 | US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 02/22/2005 | US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity |
| 02/22/2005 | US6858431 An osteoinductive soluble factor induced by the expression of human mineralization protein. |
| 02/22/2005 | US6858236 Nutriceutical and drug compositions containing a plant extract or concentrate from the genus Lycopersicon (tomato); bone disorders, e.g., Paget's disease, tumor-induced bone disease or particularly osteoporosis; metabolic disorders |
| 02/22/2005 | US6858235 Antioxidant composition and method of preparation thereof |
| 02/22/2005 | US6858206 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase |
| 02/17/2005 | WO2005014650A2 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 02/17/2005 | WO2005014593A1 Thiazole derivatives as npy antagonists |
| 02/17/2005 | WO2005014580A1 Pyridyl piperazinyl ureas |
| 02/17/2005 | WO2005014576A1 Isoquinolinone derivative, process for producing the same and use thereof |
| 02/17/2005 | WO2005014572A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005014556A1 2-aminopyrimidine derivatives |
| 02/17/2005 | WO2005014034A1 Stabilized formulation of parathyroid hormone |
| 02/17/2005 | WO2005014031A1 Use of calcitonin in osteoarthritis |
| 02/17/2005 | WO2005014027A1 Use of chemokines, and pharmaceutical preparations containing the same |
| 02/17/2005 | WO2005014026A2 Use of cxcl6 chemokine in the prevention or repair of cartilage defects |
| 02/17/2005 | WO2005014006A1 Combinations of a cathepsin k inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss |
| 02/17/2005 | WO2005013986A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005013966A1 Macrophage activation inhibitor |
| 02/17/2005 | WO2005013965A1 Use of cis-99, trans-11 isomer of conjugated linoleic acid (cla) for treating inflammatory diseases |
| 02/17/2005 | WO2005013947A2 Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer |
| 02/17/2005 | WO2005013938A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 02/17/2005 | WO2005013909A2 Novel cathepsin k inhibitors |
| 02/17/2005 | WO2004070050A3 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |
| 02/17/2005 | WO2003080568A3 Probucol derivatives |
| 02/17/2005 | WO2003070910A3 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol |
| 02/17/2005 | US20050038119 for treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis; prevention and treatment of damages caused by ischemia and reperfusion |
| 02/17/2005 | US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 02/17/2005 | US20050038084 Phenylalanine enamide derivatives |
| 02/17/2005 | US20050038073 Thiazole derivatives |
| 02/17/2005 | US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use |
| 02/17/2005 | US20050038061 6-Aminomorphinane derivatives, method for production and use thereof |
| 02/17/2005 | US20050038034 Analgesics; neurodegenerative disorders; multiple sclerosis; Parkinson's disease; neuropathic pain |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050038010 Substituted heterocyclic compounds and methods of use |
| 02/17/2005 | US20050037948 Calcium phosphopeptide complexes |
| 02/17/2005 | US20050037494 Using antisense agents to reduce and/or prevention genic expression associated with cardi-vascular complications; gene therapy |
| 02/17/2005 | US20050037430 creating a peptide database by screening, analyzing the results, characterizing a physical, chemical, or biological property of the peptides, recording; using a computer for presenting biomolecular sequence data; regulatory activity on pro- or anti-inflammatory cytokine cascades; immunoresponse |
| 02/17/2005 | US20050037097 Pyruvate enriched onion extract |